These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 6956474)
1. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina. Angus JA; Brazenor RM; Le Duc MA Clin Exp Pharmacol Physiol Suppl; 1982; 6():15-28. PubMed ID: 6956474 [TBL] [Abstract][Full Text] [Related]
2. Effects of nilvadipine on the cardiovascular system in experimental animals. Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444 [TBL] [Abstract][Full Text] [Related]
3. Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: no role for alpha adrenoceptors. Brazenor RM; Angus JA J Pharmacol Exp Ther; 1981 Aug; 218(2):530-6. PubMed ID: 6114172 [TBL] [Abstract][Full Text] [Related]
4. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog. Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852 [TBL] [Abstract][Full Text] [Related]
5. Relaxation of large coronary artery by verapamil, D600, and nifedipine is constrictor selective: comparison with glyceryl trinitrate. Angus JA; Brazenor RM J Cardiovasc Pharmacol; 1983; 5(2):321-8. PubMed ID: 6188910 [TBL] [Abstract][Full Text] [Related]
6. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies. Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945 [TBL] [Abstract][Full Text] [Related]
7. Myogenic and agonist induced responses of coronary venules after cold hyperkalaemic cardioplegia. Banitt PF; Dai HB; Wang SY; Friedman M; Sellke FW Cardiovasc Res; 1995 Jun; 29(6):827-33. PubMed ID: 7656286 [TBL] [Abstract][Full Text] [Related]
8. Interaction of epoprostenol (PGI2) with vasoconstrictors on diameter of large coronary arteries of the dog. Dusting GJ; Angus JA J Cardiovasc Pharmacol; 1984; 6(1):20-7. PubMed ID: 6199604 [TBL] [Abstract][Full Text] [Related]
9. Relaxant effects of butylidenephthalide in isolated dog blood vessels. Ko WC; Liao CC; Shih CH; Lei CB; Chen CM Planta Med; 2002 Nov; 68(11):1004-9. PubMed ID: 12451491 [TBL] [Abstract][Full Text] [Related]
10. Actions of serotonin antagonists on dog coronary artery. Brazenor RM; Angus JA Eur J Pharmacol; 1982 Jul; 81(4):569-76. PubMed ID: 6126378 [TBL] [Abstract][Full Text] [Related]
11. Reactivity of human isolated internal mammary artery to constrictor and dilator agents. Implications for treatment of internal mammary artery spasm. He GW; Rosenfeldt FL; Buxton BF; Angus JA Circulation; 1989 Sep; 80(3 Pt 1):I141-50. PubMed ID: 2766521 [TBL] [Abstract][Full Text] [Related]
12. Calcium blocking properties of piprofurol. Pourrias B; Huerta F; Santamaria R; Bowe C Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):223-39. PubMed ID: 4026458 [TBL] [Abstract][Full Text] [Related]
13. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent. Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137 [TBL] [Abstract][Full Text] [Related]
14. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)]. Nakaya H Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455 [TBL] [Abstract][Full Text] [Related]
15. Chronic cocaine treatment enhances the responsiveness of the left anterior descending coronary artery and the femoral artery to vasoactive substances. Jones LF; Tackett RL J Pharmacol Exp Ther; 1990 Dec; 255(3):1366-70. PubMed ID: 2262907 [TBL] [Abstract][Full Text] [Related]
16. Responses of dog large coronary arteries to constrictor and dilator substances: implications for the cause and treatment of variant angina pectoris. Angus JA; Brazenor RM; Le Duc MA Am J Cardiol; 1983 Jul; 52(2):52A-60A. PubMed ID: 6408920 [No Abstract] [Full Text] [Related]
17. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys. Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670 [TBL] [Abstract][Full Text] [Related]
18. Catecholamine concentrations and contractile responses of isolated vessels from hens treated with cyclic phenyl saligenin phosphate or paraoxon in the presence or absence of verapamil. McCain WC; Flaherty DM; Correll L; Jortner B; Ehrich M J Toxicol Environ Health; 1996 Jul; 48(4):397-411. PubMed ID: 8691509 [TBL] [Abstract][Full Text] [Related]
19. The combined 5-HT2 receptor and calcium channel inhibitor LU49938 restores endothelium dependent responses in the regenerated endothelium of the porcine coronary artery. Park SJ; Lee JJ; Kirchengast M; Boulanger CM; Vanhoutte PM Cardiovasc Res; 1995 Jan; 29(1):95-101. PubMed ID: 7895245 [TBL] [Abstract][Full Text] [Related]
20. Vasodilator mechanism of KB-944, a new calcium antagonist. Morita T; Kanazawa T; Ito K; Nose T Arzneimittelforschung; 1982; 32(9):1043-6. PubMed ID: 6890823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]